FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

333450001: Streptokinase+streptodornase 100,000/25,000units topical powder (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    469163015 Streptokinase+streptodornase 100,000/25,000units topical powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1193026019 Streptokinase+streptodornase 100,000/25,000units topical powder (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Streptokinase+streptodornase 100,000/25,000units topical powder Is a Product containing streptodornase and streptokinase (medicinal product) false Inferred relationship Some
    Streptokinase+streptodornase 100,000/25,000units topical powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Streptokinase (substance) false Inferred relationship Some
    Streptokinase+streptodornase 100,000/25,000units topical powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Streptodornase (substance) false Inferred relationship Some
    Streptokinase+streptodornase 100,000/25,000units topical powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Plasminogen activator false Inferred relationship Some
    Streptokinase+streptodornase 100,000/25,000units topical powder Has manufactured dose form Drug powder false Inferred relationship Some
    Streptokinase+streptodornase 100,000/25,000units topical powder Has manufactured dose form Cutaneous powder false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start